Coty Appoints New CFO Amidst Turnaround Efforts, No Immediate Thesis Change

What happened

Coty Inc. announced Soraya Benchikh will become Chief Financial Officer effective September 1, 2026, replacing Laurent Mercier. The appointment follows a July 2 operating restructure that decentralized commercial decision-making and combined R&D and supply chain. Benchikh steps in as Coty grapples with high leverage (net debt/EBITDA 4.2x), a Consumer Beauty segment that lost $127 million in FY25, and a 56% share-price decline over the past year. The CFO transition introduces execution risk but could also bring fresh perspective to cost discipline and portfolio rationalization. Management's current focus remains on stabilizing prestige fragrance growth and resolving the strategic review of Consumer Beauty.

Implication

The CFO appointment alone does not resolve Coty's fundamental challenges: high leverage, weak Consumer Beauty, and tariff headwinds. Benchikh's background and early actions will be critical to watch, particularly regarding cost reduction, working capital management, and capital allocation. Until there is evidence of stabilization in revenue and FCF, the stock remains a speculative turnaround. Any signals of accelerated deleveraging or strategic divestitures could improve the risk-reward, while missteps could further strain the balance sheet. Existing shareholders should maintain a cautious stance, and potential investors should wait for visible progress.

Thesis delta

The appointment of a new CFO does not alter the WAIT thesis at this stage. The change introduces execution uncertainty but also the possibility of improved financial discipline. Without details on Benchikh's strategy, the core concerns of leverage and Consumer Beauty profitability remain unchanged.